Gene · 9612
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NCOR2 represses MHC class I molecule expression to drive metastatic progression of breast cancer. | bioRxiv | 2025 | 40161756 | PubTator, text mining | PubMed |
| The Utah NeoSeq Project: a collaborative multidisciplinary program to facilitate genomic diagnostics in the neonatal intensive care unit. | NPJ Genom Med | 2025 | 40121231 | PubTator, text mining | PubMed |
| Comparative Evaluation and Profiling of Chemical Tools for the Nuclear Hormone Receptor Family 2. | ACS Pharmacol Transl Sci | 2025 | 40046426 | PubTator, text mining | PubMed |
| Steroid receptors and coregulators: Dissemination of sex differences and emerging technologies. | J Biol Chem | 2025 | 40023399 | PubTator, text mining | PubMed |
| Development of an Efficient and Generalized MTSCAM Model to Predict Liquid Chromatography Retention Times of Organic Compounds. | Research (Wash D C) | 2025 | 39925484 | PubTator, text mining | PubMed |
| A promising future for breast cancer therapy with hydroxamic acid-based histone deacetylase inhibitors. | Bioorg Chem | 2025 | 39862739 | PubTator, text mining | PubMed |
| Resveratrol as a BCL6 natural inhibitor suppresses germinal center derived Non-Hodgkin lymphoma cells growth. | J Nat Med | 2025 | 39815148 | PubTator, text mining | PubMed |
| Transcriptional Cofactors for Thyroid Hormone Receptors. | Endocrinology | 2025 | 39679543 | PubTator, text mining | PubMed |
| A Small-Molecule BCL6 Inhibitor as an Anti-Proliferative Agent for Diffuse Large B-Cell Lymphoma. | Mol Cancer Ther | 2025 | 39387112 | PubTator, text mining | PubMed |
| Decoding the therapeutic landscape of alpha-linolenic acid: a network pharmacology and bioinformatics investigation against cancer-related epigenetic modifiers. | J Biomol Struct Dyn | 2025 | 38088751 | PubTator, text mining | PubMed |
| HOXB13-Mediated Lipid Metabolism Regulates Prostate Cancer Metastasis. | Serican J Med | 2024 | 42146319 | PubTator, text mining | PubMed |
| SMRT-depleted conventional DCs maintain inflammation despite lower glycolysis via mTOR signalling and succinate oxidation. | NPJ Metab Health Dis | 2024 | 40604291 | PubTator, text mining | PubMed |
| Sequencing and Optical Genome Mapping for the Adventurous Chemist. | Chem Biomed Imaging | 2024 | 39735829 | PubTator, text mining | PubMed |
| MinLinMo: a minimalist approach to variable selection and linear model prediction. | BMC Bioinformatics | 2024 | 39695947 | PubTator, text mining | PubMed |
| Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application. | Signal Transduct Target Ther | 2024 | 39627201 | PubTator, text mining | PubMed |
| Exploring the ceRNA network involving AGAP2-AS1 as a novel biomarker for preeclampsia. | Sci Rep | 2024 | 39521940 | PubTator, text mining | PubMed |
| Transcriptomic analysis of genes associated with vitamin D receptor signalling reveals differences between skin cancers. | Exp Dermatol | 2024 | 39435723 | PubTator, text mining | PubMed |
| Disturbed function of TBL1X has a differential effect on T3-regulated gene expression in two human liver cell models. | Eur Thyroid J | 2024 | 39316725 | PubTator, text mining | PubMed |
| Whole exome sequencing in relapsed or refractory childhood cancer: case series. | Asian Biomed (Res Rev News) | 2024 | 39309469 | PubTator, text mining | PubMed |
| ΔNp63 bookmarks and creates an accessible epigenetic environment for TGFβ-induced cancer cell stemness and invasiveness. | Cell Commun Signal | 2024 | 39180088 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9612/papers?page=6